Yoichi Ohtaki

Profile Information

J-GLOBAL ID: 201901020791714571
researchmap Member ID: B000367263

Research Areas

Life sciences / Respiratory surgery /

Papers

Durable response to afatinib rechallenge in a long-term survivor of non-small cell lung cancer harboring EGFR L858R and L747V mutations.

Mio Kanbe, Noriaki Sunaga, Kenichiro Hara, Hiiru Sawada, Ikuo Wakamatsu, Kentaro Hara, Sohei Muto, Yuri Sawada, Hiroaki Masubuchi, Mari Sato, Yosuke Miura, Hiroaki Tsurumaki, Masakiyo Yatomi, Reiko Sakurai, Yasuhiko Koga, Yoichi Ohtaki, Toshiteru Nagashima, Naoko Okano, Nobuteru Kubo, Toshitaka Maeno, Takeshi Hisada

Thoracic cancer, Oct 4, 2022
RAB11A Expression Is Associated With Cancer Aggressiveness Through Regulation of FGFR-Signaling in Lung Squamous Cell Carcinoma.

Navchaa Gombodorj, Yoko Azuma, Takehiko Yokobori, Bilguun Erkhem-Ochir, Takayuki Kosaka, Yoichi Ohtaki, Seshiru Nakazawa, Akira Mogi, Toshiki Yajima, Hiroyuki Kuwano, Hiroshi Saeki, Ken Shirabe

Annals of surgical oncology, 29(11) 7149-7162, Oct, 2022
Molecular and expressional characterization of tumor heterogeneity in pulmonary carcinosarcoma.

Yoichi Ohtaki, Reika Kawabata-Iwakawa, Sumihito Nobusawa, Yusuke Goto, Kimihiro Shimizu, Toshiki Yajima, Seshiru Nakazawa, Natsuko Kawatani, Yuka Yoshida, Takaaki Sano, Ken Shirabe

Molecular carcinogenesis, Jul 18, 2022
Surgical outcomes after multiple segmentectomy: a cohort study.

Seshiru Nakazawa, Kimihiro Shimizu, Natsuko Kawatani, Kai Obayashi, Yoichi Ohtaki, Takayuki Kosaka, Toshiki Yajima, Ken Shirabe

Journal of thoracic disease, 14(1) 113-122, Jan, 2022
肺原発大細胞神経内分泌腫瘍における化学療法感受性マーカー発現と予後・腫瘍免疫との関連について

大瀧容一, 解良恭一, 矢島俊樹, 川島修, 上吉原光宏, 井貝仁, 小野里良一, 伊部崇史, 高坂貴行, 永島宗晃, 尾林海, 中澤世識, 河谷菜津子, 矢澤友弘, 小山徹也, 調憲

肺癌, 61(6) 651-651, Oct, 2021
Comprehensive expressional analysis of chemosensitivity-related markers in large cell neuroendocrine carcinoma of the lung.

Yoichi Ohtaki, Kyoichi Kaira, Toshiki Yajima, Bilguun Erkhem-Ochir, Osamu Kawashima, Mitsuhiro Kamiyoshihara, Hitoshi Igai, Ryoichi Onozato, Takashi Ibe, Takayuki Kosaka, Seshiru Nakazawa, Toshiteru Nagashima, Tetsunari Oyama, Ken Shirabe

Thoracic cancer, Aug 28, 2021
Superior Lingular S4 Segmentectomy.

Seshiru Nakazawa, Toshiki Yajima, Kazuki Numajiri, Natsuko Kawatani, Kai Obayashi, Yoichi Ohtaki, Toshiteru Nagashima, Kimihiro Shimizu, Ken Shirabe

The Annals of thoracic surgery, 113(2) e141-e144, May 1, 2021
Salvage surgery for non-small cell lung cancer after tyrosine kinase inhibitor treatment

Yoichi Ohtaki, Kimihiro Shimizu, Hiroyuki Suzuki, Kenji Suzuki, Masahiro Tsuboi, Tetsuya Mitsudomi, Motoshi Takao, Tomohiro Murakawa, Hiroyuki Ito, Kenichi Yoshimura, Morihito Okada, Masayuki Chida

Lung Cancer, 153 108-116, Mar, 2021
肺癌肉腫の1切除例

遠藤瑞貴, 中澤世識, 沼尻一樹, 河谷菜津子, 尾林海, 大瀧容一, 伊部崇史, 矢島俊樹, 調憲, 白倉貴洋, 松村望, 横尾英明

肺癌, 60(7) 1022-1023, Dec, 2020
Right upper lobe segmentectomy guided by simplified anatomic models

Seshiru Nakazawa, Kimihiro Shimizu, Natsuko Kawatani, Kai Obayashi, Yoichi Ohtaki, Toshiteru Nagashima, Takashi Eguchi, Toshiki Yajima, Ken Shirabe

JTCVS Techniques, 4 288-297, Dec, 2020
Quantitative analysis of metabolic parameters at 18F-fluorodeoxyglucose positron emission tomography in predicting malignant potential of anterior mediastinal tumors.

Toshiki Yajima, Akira Mogi, Kimihiro Shimizu, Takayuki Kosaka, Yoichi Ohtaki, Kai Obayashi, Seshiru Nakazawa, Takahito Nakajima, Yoshito Tsushima, Ken Shirabe

Oncology letters, 19(3) 1865-1871, Mar, 2020 Peer-reviewed
Prognostic Significance of Glucose Metabolism as GLUT1 in Patients with Pulmonary Pleomorphic Carcinoma.

Hisao Imai, Kyoichi Kaira, Hideki Endoh, Kazuyoshi Imaizumi, Yasuhiro Goto, Mitsuhiro Kamiyoshihara, Takayuki Kosaka, Toshiki Yajima, Yoichi Ohtaki, Takashi Osaki, Yoshihito Kogure, Shigebumi Tanaka, Atsushi Fujita, Tetsunari Oyama, Koichi Minato, Takayuki Asao, Ken Shirabe

Journal of clinical medicine, 9(2), Feb 3, 2020
Prognostic Significance of Glucose Metabolism as GLUT1 in Patients with Pulmonary Pleomorphic Carcinoma

Hisao Imai, Kyoichi Kaira, Hideki Endoh, Kazuyoshi Imaizumi, Yasuhiro Goto, Mitsuhiro Kamiyoshihara, Takayuki Kosaka, Toshiki Yajima, Yoichi Ohtaki, Takashi Osaki, Yoshihito Kogure, Shigebumi Tanaka, Atsushi Fujita, Tetsunari Oyama, Koichi Minato, Takayuki Asao, Ken Shirabe

JOURNAL OF CLINICAL MEDICINE, 9(2), Feb, 2020
Clinicopathological features of small-sized peripheral squamous cell lung cancer.

Kosaka T, Shimizu K, Nakazawa S, Iijima M, Ohtaki Y, Azuma Y, Obayashi K, Nagashima T, Yajima T, Mogi A, Kuwano H, Shirabe K

Molecular and clinical oncology, 12(1) 69-74, Jan, 2020 Peer-reviewed
Significance of RAS mutations in pulmonary metastases of patients with colorectal cancer.

Igarashi T, Shimizu K, Usui K, Yokobori T, Ohtaki Y, Nakazawa S, Obayashi K, Yajima T, Nobusawa S, Ohkawa T, Katoh R, Motegi Y, Ogawa H, Harimoto N, Ichihara T, Mitani Y, Yokoo H, Mogi A, Shirabe K

International journal of clinical oncology, Nov, 2019 Peer-reviewed
Pulmonary Artery Compression Facilitates Intersegmental Border Visualization.

Yajima T, Shimizu K, Mogi A, Ibe T, Ohtaki Y, Obayashi K, Nakazawa S, Kawatani N, Shirabe K

The Annals of thoracic surgery, 108(2) e141-e143, Aug, 2019 Peer-reviewed
Stathmin-1 Is a Useful Diagnostic Marker for High-Grade Lung Neuroendocrine Tumors.

Shimizu K, Goto Y, Kawabata-Iwakawa R, Ohtaki Y, Nakazawa S, Yokobori T, Obayashi K, Kawatani N, Yajima T, Kaira K, Mogi A, Hirato J, Nishiyama M, Shirabe K

The Annals of thoracic surgery, 108(1) 235-243, Jul, 2019 Peer-reviewed
Is salvage surgery for patients with lung cancer after carbon ion radiotherapy easy or difficult?

Ohtaki Y, Shimizu K, Saitoh JI, Kamiyoshihara M, Mogi A, Nakazawa S, Ohno T, Shirabe K

Interactive cardiovascular and thoracic surgery, 28(6) 953-956, Jun, 2019 Peer-reviewed
Genetic and Immunohistochemical Studies Investigating the Histogenesis of Neuroendocrine and Carcinomatous Components of Combined Neuroendocrine Carcinoma.

Iijima M, Yokobori T, Mogi A, Shimizu K, Yajima T, Kosaka T, Ohtaki Y, Obayashi K, Nakazawa S, Gombodorj N, Tsukagoshi M, Shirabe K, Kuwano H

Annals of surgical oncology, 26(6) 1744-1750, Jun, 2019 Peer-reviewed
Minimally Invasive Open-Window Thoracostomy Using Wound Edge Protectors.

Shimizu K, Ohtaki Y, Nakazawa S, Obayashi K, Nagashima T, Yajima T, Mogi A, Shirabe K

The Annals of thoracic surgery, 107(5) e371-e373, May, 2019 Peer-reviewed

Misc.

218

肺原発大細胞神経内分泌腫瘍における化学療法感受性マーカー発現と予後・腫瘍免疫との関連について

大瀧容一, 解良恭一, 矢島俊樹, 川島修, 上吉原光宏, 井貝仁, 小野里良一, 伊部崇史, 高坂貴行, 永島宗晃, 尾林海, 中澤世識, 河谷菜津子, 矢澤友弘, 小山徹也, 調憲

肺癌, 61(6) 651-651, Oct, 2021
肺癌肉腫の1切除例

遠藤瑞貴, 中澤世識, 沼尻一樹, 河谷菜津子, 尾林海, 大瀧容一, 伊部崇史, 矢島俊樹, 調憲, 白倉貴洋, 松村望, 横尾英明

肺癌, 60(7) 1022-1023, Dec, 2020
cN0左上葉原発肺癌に対する区域切除術の根治性肺葉切除は本当に必要か?

永島宗晃, 矢島俊樹, 大瀧容一, 尾林海, 中澤世識, 河谷菜津子, 沼尻一樹, 調憲

肺癌, 60(6) 612-612, Oct, 2020
原発性肺癌と大腸癌肺転移の術前鑑別診断予測スコアの有用性

大瀧容一, 矢島俊樹, 伊部崇史, 永島宗晃, 尾林海, 中澤世識, 河谷菜津子, 沼尻一樹, 調憲

肺癌, 60(6) 616-616, Oct, 2020
左上下葉間に生じた転移性肺腫瘍に対し、S5+S8区域切除にて切除を行なった1例

尾林海, 矢島俊樹, 永島宗晃, 大瀧容一, 中澤世識, 河谷菜津子, 沼尻一樹, 調憲

肺癌, 60(6) 739-739, Oct, 2020
発見から17年後に手術切除を行った、胸膜solitary fibrous tumorと胸腺腫を合併した1例

成澤英司, 尾林海, 沼尻一樹, 河谷奈津子, 中澤世識, 大瀧容一, 永島宗晃, 矢島俊樹, 調憲

日本臨床外科学会雑誌, 81(増刊) 477-477, Oct, 2020
術後気管支断端瘻発症におけるリスク因子の検討

伊部崇史, 矢島俊樹, 沼尻一樹, 河谷菜津子, 中澤世識, 尾林海, 大瀧容一, 調憲

日本外科学会定期学術集会抄録集, 120回 DP-3, Aug, 2020
非小細胞肺癌に対する積極的縮小手術の適応と限界

中澤世識, 沼尻一樹, 河谷菜津子, 尾林海, 大瀧容一, 伊部崇史, 矢島俊樹, 清水公裕, 調憲

日本外科学会定期学術集会抄録集, 120回 DP-3, Aug, 2020
人工気胸併用完全胸腔鏡下に切除した右肺尖部胸壁腫瘍の1例

河谷菜津子, 矢島俊樹, 沼尻一樹, 中澤世識, 尾林海, 大瀧容一, 伊部崇史, 調憲

日本呼吸器外科学会雑誌, 34(3) V8-4, Aug, 2020
術前血清D-dimer値を用いた深部静脈血栓症のリスク評価

沼尻一樹, 矢島俊樹, 河谷菜津子, 中澤世識, 尾林海, 大瀧容一, 伊部崇史, 調憲

日本呼吸器外科学会雑誌, 34(3) O17-2, Aug, 2020
左肺上葉上区の区域切除術式とその合併症について

大瀧容一, 矢島俊樹, 河谷菜津子, 沼尻一樹, 中澤世識, 尾林海, 伊部崇史, 調憲

日本呼吸器外科学会雑誌, 34(3) O20-3, Aug, 2020
原発性肺癌術後1年以内再発例の臨床病理学的検討

伊部崇史, 矢島俊樹, 沼尻一樹, 河谷菜津子, 中澤世識, 尾林海, 大瀧容一, 調憲

日本呼吸器外科学会雑誌, 34(3) O21-7, Aug, 2020
GGN肺癌におけるC/T ratioは予後への影響は小さいが、縮小手術の適応基準として考慮できる

尾林海, 沼尻一樹, 河谷菜津子, 中澤世識, 大瀧容一, 伊部崇史, 矢島俊樹, 調憲

日本呼吸器外科学会雑誌, 34(3) O41-6, Aug, 2020
完全鏡視下肺葉切除での術後肺瘻0を目指すための工夫

矢島俊樹, 伊部崇史, 大瀧容一, 尾林海, 中澤世識, 河谷菜津子, 田中司玄文, 調憲

日本呼吸器外科学会雑誌, 34(3) MO13-2, Aug, 2020
左肺舌区の非定型区域切除の検討

中澤世識, 沼尻一樹, 河谷菜津子, 尾林海, 大瀧容一, 伊部崇史, 矢島俊樹, 清水公裕, 調憲

日本呼吸器外科学会雑誌, 34(3) MO45-5, Aug, 2020
術中イメージング-モニタリングを駆使した最新手術- 肺区域間同定におけるICG静注法と選択的気管支送気法併用の有効性

矢島俊樹, 清水公裕, 沼尻一樹, 河谷菜津子, 中澤世識, 尾林海, 大瀧容一, 伊部崇史, 調憲

日本外科学会定期学術集会抄録集, 120回 WS-1, Aug, 2020
急激な増大を来たし、血胸を契機に診断された胸腔内原発滑膜肉腫の1例

荒木健, 尾林海, 沼尻一樹, 河谷菜津子, 中澤世識, 大瀧容一, 伊部崇史, 矢島俊樹, 調憲, 越浩美

肺癌, 60(2) 130-131, Apr, 2020
外科切除により軽快したIGF-2産生巨大胸腔内孤立性線維性腫瘍による遷延性低血糖症の1例

関貴臣, 矢島俊樹, 沼尻一樹, 河谷菜津子, 中澤世識, 尾林海, 大瀧容一, 伊部崇史, 調憲

日本胸部外科学会関東甲信越地方会要旨集, (182回) 20-20, Mar, 2020
原発性肺癌と大腸癌肺転移の術前鑑別診断予測スコアの有用性の検討

伊部崇史, 清水公裕, 大瀧容一, 沼尻一樹, 河谷菜津子, 中澤世識, 尾林海, 矢島俊樹, 調憲

肺癌, 59(6) 683-683, Nov, 2019
混合型高悪性度肺神経内分泌腫瘍におけるStathmin 1(STMN1)免疫染色の有用性

後藤優典, 清水公裕, 河谷菜津子, 中澤世識, 尾林海, 大瀧容一, 矢島俊樹, 伊部崇史, 調憲

肺癌, 59(6) 914-914, Nov, 2019

Research Projects

肺がんに対するリガンド型CAR-T細胞治療の開発

科学研究費助成事業基盤研究(C), 日本学術振興会, Apr, 2022 - Mar, 2025

清水公裕, 大瀧容一, 濱中一敏, 江口隆, 三島修治, 三浦健太郎, 竹田哲
Identification of novel immune check point molecules in exhausted CD8+ T cells

Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C), Japan Society for the Promotion of Science, Apr, 2021 - Mar, 2024
マウスモデルを用いた免疫チェックポイント阻害剤の新たな治療抵抗メカニズムの解明

科学研究費助成事業基盤研究(C), 日本学術振興会, Apr, 2020 - Mar, 2023

河谷菜津子, 矢島俊樹, 大瀧容一, 中澤世識
Elucidation of anticancer drug resistance mechanism of lung cancer through FOXM1

Grants-in-Aid for Scientific Research Grant-in-Aid for Scientific Research (C), Japan Society for the Promotion of Science, Apr, 2020 - Mar, 2023
Molecular biological analysis of thymic epithelial tumor for personalized medicine

Grants-in-Aid for Scientific Research Grant-in-Aid for Young Scientists (B), Japan Society for the Promotion of Science, Apr, 2014 - Mar, 2017

Ohtaki Yoichi, SHIMIZU Kimihiro, KAIRA Kyoichi

Profile Information

Research Areas

Papers

Misc.

Research Projects

Menu

Coauthors